DLK1 and metabolic dysfunction-associated steatotic liver disease: Indeed, our preliminary study in human NAFLD patients indicated that serum levels of the respective human homologs of the candidate Dlk1-Dio3 mat miRNAs are related to NAFLD progression [25].